Ziopharm Oncology
ZIOP
$0.87
Share price
-0.88%
Change (1 day)
-74.86%
Change (1 year)
Categories
Revenue for Ziopharm Oncology (ZIOP)
Revenue in 2021 (TTM): $3.73 M
According to Ziopharm Oncology's latest financial reports the company's current revenue (TTM) is $3.73 M. In 2017 the company made a revenue of $6.38 M a decrease over the years 2016 revenue that were of $6.86 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Ziopharm Oncology from 2001 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $3.73 M | |
| 2017 | $6.38 M | -6.88% |
| 2016 | $6.86 M | 58.38% |
| 2015 | $4.33 M | 215.51% |
| 2014 | $1.37 M | 71.63% |
| 2013 | $0.8 M | 0% |
| 2012 | $0.8 M | 19.94% |
| 2011 | $0.66 M | |
| 2001 | $0 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $28.19 B | 753,844.91% | 🇺🇸 USA |
 Baxter BAX | $14.89 B | 398,188.31% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.53 B | 1,217,712.25% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | $0.63 M | -83.10% | 🇺🇸 USA |